Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
EUROPEAN JOURNAL OF CANCER. SUPPLEMENT
Rivista
Codice:
E192402
ISSN:
1359-6349
Dati Generali
Dati Generali
Pubblicazioni (10)
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel
Abstract
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial
Abstract
Clinical application of 11C-Choline PET in patients with biochemical relapse of prostate cancer
Abstract
Cytotoxic treatment for rectal cancer reveals different innate immunity in responder and non-responder patients
Abstract
DGKa, by regulating atypical PKC, is a key transducer of SDF1a-induced invasive behaviour in breast cancer cells
Abstract
Preliminary evidences for recruitment of innate responses to rectal cancer cell death elicited by neo-adjuvant radio-chemo therapy
Abstract
Preliminary results of a phase II trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinorna
Abstract
Prognostic significance of resection line involvement after gastric cancer surgery: a single western centre experience
Articolo
Prognostic significance of resection line involvement after gastric surgery: a single western centreexperience
Abstract
Prognostic value of carbohydrate antigen (CA)19-9 decrease in response to chemotherapy for advanced pancreatic adenocarcinoma (PA)
Abstract
No Results Found
